Mirum and Incyte Report Positive Phase 2 Results f...
Category : Clinical Trial Update 15 June 2026New Data Highlights Strong Disease Control in Patients with FOP Mirum Pharmaceuticals and Incyte...
New Data Highlights Strong Disease Control in Patients with FOP Mirum Pharmaceuticals and Incyte...
Company Announces Progress in Phase 3 Studies of Insulin Ludefen and Bofanglutide Gan & Lee P...
Belite Bio Reaches Important Regulatory Milestone Belite Bio has announced the completion of its...
Takeda has announced positive topline results from its Phase 3 LATITUDE Atlas study evaluating zasoc...
ENERGY Study Shows Significant Hemoglobin Improvement in Patients with Rare Blood Disorder Johnso...